150 related articles for article (PubMed ID: 2232367)
1. Amyloidosis (AA type) with gastrointestinal involvement: resolution of gastric amyloid deposition in parallel with disappearance of the serum component of amyloid A protein.
Nomura S; Matsutani T; Shindo T; Kimura K; Osawa G; Kozuka K
Jpn J Med; 1990; 29(2):180-4. PubMed ID: 2232367
[TBL] [Abstract][Full Text] [Related]
2. [Case of acute necrotizing esophagitis associated with AA amyloidosis secondary to bronchiectasis].
Hasatani K; Shibata N; Naitou Y; Torii Y; Nishiyama S; Takahashi K; Fujinaga H; Hayashi Y; Aoyagi H; Tatsumi S; Ibe N; Urasaki K; Kaizaki Y
Nihon Shokakibyo Gakkai Zasshi; 2014 Feb; 111(2):288-95. PubMed ID: 24500318
[TBL] [Abstract][Full Text] [Related]
3. Amyloid A gastrointestinal amyloidosis associated with idiopathic retroperitoneal fibrosis. Report of a rare autopsy case and review of the literature.
Hosaka N; Ito M; Taki Y; Iwai H; Toki J; Ikehara S
Arch Pathol Lab Med; 2003 Jun; 127(6):735-8. PubMed ID: 12741901
[TBL] [Abstract][Full Text] [Related]
4. Secondary (AA-type) amyloidosis in patients with polymyalgia rheumatica.
Escribá A; Morales E; Albizúa E; Herrero JC; Ortuño T; Carreño A; Dominguez-Gil B; Praga M
Am J Kidney Dis; 2000 Jan; 35(1):137-40. PubMed ID: 10620555
[TBL] [Abstract][Full Text] [Related]
5. Development of gastrointestinal beta2-microglobulin amyloidosis correlates with time on dialysis.
Jimenez RE; Price DA; Pinkus GS; Owen WF; Lazarus JM; Kay J; Turner JR
Am J Surg Pathol; 1998 Jun; 22(6):729-35. PubMed ID: 9630180
[TBL] [Abstract][Full Text] [Related]
6. Visceral organ involvement and extracellular matrix changes in beta 2-microglobulin amyloidosis--a comparative study with systemic AA and AL amyloidosis.
Ohashi K; Takagawa R; Hara M
Virchows Arch; 1997 Jun; 430(6):479-87. PubMed ID: 9230913
[TBL] [Abstract][Full Text] [Related]
7. Alveolar hydatid cyst (AHC): inflammation-induced reactive gastrointestinal (GL) amyloidosis in AHC-infected mice and chemical characterization of the GL amyloid.
Li W; Chan SL; Chronopoulos S; Bell A; Ali-Khan Z
Exp Parasitol; 1996 Jun; 83(1):1-10. PubMed ID: 8654537
[TBL] [Abstract][Full Text] [Related]
8. Systemic AA amyloidosis.
Pinney JH; Lachmann HJ
Subcell Biochem; 2012; 65():541-64. PubMed ID: 23225016
[TBL] [Abstract][Full Text] [Related]
9. Clinical and histological characteristics of renal AA amyloidosis: a retrospective study of 68 cases with a special interest to amyloid-associated inflammatory response.
Verine J; Mourad N; Desseaux K; Vanhille P; Noël LH; Beaufils H; Grateau G; Janin A; Droz D
Hum Pathol; 2007 Dec; 38(12):1798-809. PubMed ID: 17714761
[TBL] [Abstract][Full Text] [Related]
10. Amyloid A (AA) amyloidosis in CByB6 mice: a model to study gastrointestinal amyloidosis.
Gahane AY; Thakur AK
Amyloid; 2017 Mar; 24(sup1):144-145. PubMed ID: 28434288
[No Abstract] [Full Text] [Related]
11. Gastrointestinal AAPOAII and systemic AA-amyloidosis in aged C57BL/Ka mice. Amyloid-type dependent effect of long-term immunosuppressive treatment.
HogenEsch H; Niewold TA; Higuchi K; Tooten PC; Gruys E; Radl J
Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 64(1):37-43. PubMed ID: 8401815
[TBL] [Abstract][Full Text] [Related]
12. Hepatic amyloidosis: morphologic spectrum of histopathological changes in AA and nonAA amyloidosis.
Sarsik B; Sen S; Kirdok FS; Akarca US; Toz H; Yilmaz F
Pathol Res Pract; 2012 Dec; 208(12):713-8. PubMed ID: 23154038
[TBL] [Abstract][Full Text] [Related]
13. Amyloid a protein amyloidosis in a patient with plasma cell dyscrasia.
Ishikawa H; Nakata K; Aritomi T; Ohkubo K; Migita K; Hamasaki K; Yamasaki S; Nakao K; Kato Y; Hayashi T; Eguchi K
Intern Med; 2002 May; 41(5):386-91. PubMed ID: 12058889
[TBL] [Abstract][Full Text] [Related]
14. Noncerebral Amyloidoses: Aspects on Seeding, Cross-Seeding, and Transmission.
Westermark GT; Fändrich M; Lundmark K; Westermark P
Cold Spring Harb Perspect Med; 2018 Jan; 8(1):. PubMed ID: 28108533
[TBL] [Abstract][Full Text] [Related]
15. End-stage renal failure from renal amyloidosis of the AA type associated with giant lymph node hyperplasia (Castleman's disease).
Montoli A; Minola E; Stabile F; Grillo C; Radaelli L; Spanti D; Luccarelli E; Spata C; Minetti L
Am J Nephrol; 1995; 15(2):142-6. PubMed ID: 7733151
[TBL] [Abstract][Full Text] [Related]
16. Deposition, Clearance, and Reinduction of Amyloid A Amyloid in Interleukin 1 Receptor Antagonist Knockout Mice.
Watanabe K; Uchida K; Chambers JK; Ushio N; Nakayama H
Vet Pathol; 2017 Jan; 54(1):99-110. PubMed ID: 27565681
[TBL] [Abstract][Full Text] [Related]
17. Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value.
Jager PL; Hazenberg BP; Franssen EJ; Limburg PC; van Rijswijk MH; Piers DA
J Nucl Med; 1998 Apr; 39(4):699-706. PubMed ID: 9544684
[TBL] [Abstract][Full Text] [Related]
18. Histomorphological variations in systemic AA amyloidosis: clues of AA protein polymorphism.
Looi LM
Histopathology; 1989 Feb; 14(2):111-20. PubMed ID: 2707747
[TBL] [Abstract][Full Text] [Related]
19. Transmission of systemic AA amyloidosis in animals.
Murakami T; Ishiguro N; Higuchi K
Vet Pathol; 2014 Mar; 51(2):363-71. PubMed ID: 24280941
[TBL] [Abstract][Full Text] [Related]
20. Homozygous serum amyloid P component-deficiency does not enhance regression of AA amyloid deposits.
Usui I; Kawano H; Ito S; Hamada Y; Ishihara T; Maeda S
Amyloid; 2001 Jun; 8(2):101-4. PubMed ID: 11409030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
